The stock of ChemoCentryx, Inc. (NASDAQ:CCXI) is a huge mover today! The stock decreased 3.27% or $0.36 during the last trading session, reaching $10.66. About 68,213 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 12.22% since March 21, 2018 and is uptrending. It has outperformed by 7.85% the S&P500. Some Historical CCXI News: 20/04/2018 – DJ Chemocentryx Inc, Inst Holders, 1Q 2018 (CCXI); 09/05/2018 – CHEMOCENTRYX INC – QTRLY DILUTED NET LOSS PER COMMON SHARE $0.19; 09/03/2018 ChemoCentryx 4Q EPS 80c; 03/04/2018 – ChemoCentryx Presenting at Conference Apr 9; 10/05/2018 – Invus Public Equities Advisors Exits Position in ChemoCentryx; 09/05/2018 – ChemoCentryx 1Q Loss/Shr 19c; 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 09/03/2018 – CHEMOCENTRYX INC QUARTERLY SHR $0.80; 13/03/2018 – CHEMOCENTRYX INC CCXI.O : JP MORGAN RAISES TARGET PRICE TO $16 FROM $13; 11/04/2018 – ChemoCentryx Announces Presentation During National Kidney Foundation 2018 Spring Clinical MeetingThe move comes after 7 months negative chart setup for the $560.39 million company. It was reported on Mar, 21 by Barchart.com. We have $10.02 PT which if reached, will make NASDAQ:CCXI worth $33.62 million less.
Flushing Financial Corp (FFIC) investors sentiment increased to 1.03 in Q4 2018. It’s up 0.14, from 0.89 in 2018Q3. The ratio is positive, as 38 investment professionals increased and opened new equity positions, while 37 sold and trimmed equity positions in Flushing Financial Corp. The investment professionals in our database now possess: 21.46 million shares, down from 21.48 million shares in 2018Q3. Also, the number of investment professionals holding Flushing Financial Corp in top ten equity positions was flat from 1 to 1 for the same number . Sold All: 5 Reduced: 32 Increased: 25 New Position: 13.
Flushing Financial Corporation operates as the bank holding firm for Flushing Bank that provides banking services and products primarily to consumers, businesses, and governmental units. The company has market cap of $613.78 million. The firm offers various deposit products, including checking and savings accounts, money market accounts, demand accounts, NOW accounts, and certificates of deposit. It has a 11.48 P/E ratio. The Company’s loan portfolio comprises mortgage loans secured by multi-family residential, commercial real estate, one-to-four family mixed-use property, one-to-four family residential property, and commercial business loans; construction loans; small business administration loans and other small business loans; mortgage loan surrogates, such as mortgage-backed securities; the United States government securities, corporate fixed-income securities, and other marketable securities; and consumer loans, including overdraft lines of credit.
Teton Advisors Inc. holds 1.48% of its portfolio in Flushing Financial Corporation for 628,192 shares. Kestrel Investment Management Corp owns 110,275 shares or 1.2% of their US portfolio. Moreover, Alphaone Investment Services Llc has 0.86% invested in the company for 96,826 shares. The Tennessee-based Martin & Co Inc Tn has invested 0.47% in the stock. Frontier Capital Management Co Llc, a Massachusetts-based fund reported 2.52 million shares.
Analysts await Flushing Financial Corporation (NASDAQ:FFIC) to report earnings on April, 23. They expect $0.38 earnings per share, up 2.70% or $0.01 from last year’s $0.37 per share. FFIC’s profit will be $10.59 million for 14.49 P/E if the $0.38 EPS becomes a reality. After $0.54 actual earnings per share reported by Flushing Financial Corporation for the previous quarter, Wall Street now forecasts -29.63% negative EPS growth.
The stock increased 0.59% or $0.13 during the last trading session, reaching $22.03. About 22,656 shares traded. Flushing Financial Corporation (FFIC) has declined 14.48% since March 21, 2018 and is downtrending. It has underperformed by 18.85% the S&P500. Some Historical FFIC News: 18/05/2018 – Flushing Financial Closes Above 50-Day Moving Average; 22/04/2018 – DJ Flushing Financial Corporation, Inst Holders, 1Q 2018 (FFIC); 24/04/2018 – FLUSHING FINANCIAL CORP FFIC.O – QTRLY CORE DILUTED EPS WAS $0.37,DOWN 7.5% YOY; 24/04/2018 – Flushing Financial Corporation Reports Record Commercial Business Loan Originations; 10.5% Annualized Net Loan Growth; 24/04/2018 – FLUSHING FINANCIAL CORP – INCREASED QUARTERLY DIVIDEND BY 11% TO $0.20 PER SHARE; 25/04/2018 – Flushing Financial Closes Below 50-Day Average: Technicals; 24/04/2018 – Flushing Financial 1Q EPS 39c; 24/04/2018 – FLUSHING FINANCIAL 1Q CORE EPS 37C, EST. 45C; 30/05/2018 – Flushing Financial Corporation Declares Quarterly Dividend of $0.20 per Share; 19/04/2018 – Flushing Bank Leases New Chinatown Branch Location
More notable recent Flushing Financial Corporation (NASDAQ:FFIC) news were published by: Seekingalpha.com which released: “Flushing Financial declares $0.21 dividend – Seeking Alpha” on February 26, 2019, also Nasdaq.com with their article: “Flushing Financial Corporation Reports the Death of Senior Executive Vice President, John F. Stewart – Nasdaq” published on February 05, 2019, Globenewswire.com published: “Flushing Financial Corporation to Host Fourth Quarter 2018 Earnings Call – GlobeNewswire” on December 27, 2018. More interesting news about Flushing Financial Corporation (NASDAQ:FFIC) were released by: Globenewswire.com and their article: “Flushing Financial Corporation Declares Quarterly Dividend of $0.20 per Share – GlobeNewswire” published on November 20, 2018 as well as Globenewswire.com‘s news article titled: “Flushing Financial Corporation to meet with Institutional Investors – GlobeNewswire” with publication date: March 05, 2019.
Since October 16, 2018, it had 0 insider buys, and 8 selling transactions for $87.64 million activity. The insider Cappel Markus J. sold 6,172 shares worth $74,079. $86,554 worth of ChemoCentryx, Inc. (NASDAQ:CCXI) was sold by Schall Thomas J.. Shares for $85.85 million were sold by GLAXOSMITHKLINE PLC on Tuesday, October 16. $457,747 worth of stock was sold by KANAYA SUSAN M on Tuesday, January 22.
More important recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Nasdaq.com which released: “ChemoCentryx (CCXI) Reports Q4 Loss, Lags Revenue Estimates – Nasdaq” on March 11, 2019, also Nasdaq.com published article titled: “ChemoCentryx (CCXI) Looks Good: Stock Adds 5.5% in Session – Nasdaq”, Nasdaq.com published: “After-Hours Earnings Report for March 11, 2019 : ADT, COUP, SFIX, DRNA, AVD, PETQ, CCXI, LXFR, MG, OXFD, FRTA, KALA – Nasdaq” on March 11, 2019. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) was released by: Globenewswire.com and their article: “New Research: Key Drivers of Growth for Ellie Mae, Spotify Technology SA, Bristow Group, Teradata, ChemoCentryx, and AgroFresh Solutions â€” Factors of Influence, Major Initiatives and Sustained Production – GlobeNewswire” with publication date: February 26, 2019.
Among 4 analysts covering ChemoCentryx (NASDAQ:CCXI), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. ChemoCentryx had 4 analyst reports since November 12, 2018 according to SRatingsIntel. On Monday, November 12 the stock rating was maintained by Canaccord Genuity with “Buy”. The company was maintained on Tuesday, March 12 by H.C. Wainwright. The stock has “Buy” rating by Leerink Swann on Thursday, February 14.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.